Dr Tedros Calls On Member States To Step Up Political Leadership & Investment For Health Impact 20/05/2019 David Branigan Health is about political leadership, partnership and people, Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, said today in his opening address of the 72nd World Health Assembly in Geneva, adding that these three priorities must guide discussions not only this week, but throughout the next year. Image Credits: WHO/Laurent Cipriani. Continue reading -> G-Finder Report: Global Funding For R&D In Neglected Diseases Increasing, Overreliance On US Funding Dangerous 13/12/2017 Catherine Saez A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is "unparalleled," and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found. Continue reading -> The Case Against Fauci Was Never About the Origins of COVID-19 11/08/2026 Stefan Anderson For nearly three hours on 29 July, the US Senate Homeland Security and Governmental Affairs Committee heard one sentence repeated over a hundred times. “On the advice of counsel, I respectfully decline to answer based upon my rights under the Fifth Amendment of the Constitution.” Dr Anthony Fauci, the 85-year-old retired director of the National […] Continue reading -> EXCLUSIVE: US Candidates Among Those Shortlisted in Contentious Global Fund Leadership Race 28/06/2026 Felix Sassmannshausen & Elaine Ruth Fletcher As the Global Fund to Fight AIDS, Tuberculosis and Malaria heads into a secretive but highly contentious election of a new Executive Director, the names of several candidates reported to be on the shortlist, all US citizens, have surfaced. They include former Global Fund Executive Director Mark Dybul, former Trump appointee William Steiger and […] Continue reading -> As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon 24/06/2026 Kerry Cullinan A clinical trial of two antivirals that may be effective in treating Ebola Bundibugyo is expected to start in the Democratic Republic of Congo (DRC) next week. “The trial will evaluate whether MVPC 134 and remdesivir can help to reduce mortality in patients with Bundibugyo virus disease, alone or in combination,” World Health Organization (WHO) […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
G-Finder Report: Global Funding For R&D In Neglected Diseases Increasing, Overreliance On US Funding Dangerous 13/12/2017 Catherine Saez A report released today on global funding of research and development for neglected diseases found that global funding has increased but warns that overreliance on funding from the United States, which the report says is "unparalleled," and leads to a heavy concentration of global funding on HIV/AIDS, malaria and tuberculosis. This overreliance could also lead to change in total global funding, the report found. Continue reading -> The Case Against Fauci Was Never About the Origins of COVID-19 11/08/2026 Stefan Anderson For nearly three hours on 29 July, the US Senate Homeland Security and Governmental Affairs Committee heard one sentence repeated over a hundred times. “On the advice of counsel, I respectfully decline to answer based upon my rights under the Fifth Amendment of the Constitution.” Dr Anthony Fauci, the 85-year-old retired director of the National […] Continue reading -> EXCLUSIVE: US Candidates Among Those Shortlisted in Contentious Global Fund Leadership Race 28/06/2026 Felix Sassmannshausen & Elaine Ruth Fletcher As the Global Fund to Fight AIDS, Tuberculosis and Malaria heads into a secretive but highly contentious election of a new Executive Director, the names of several candidates reported to be on the shortlist, all US citizens, have surfaced. They include former Global Fund Executive Director Mark Dybul, former Trump appointee William Steiger and […] Continue reading -> As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon 24/06/2026 Kerry Cullinan A clinical trial of two antivirals that may be effective in treating Ebola Bundibugyo is expected to start in the Democratic Republic of Congo (DRC) next week. “The trial will evaluate whether MVPC 134 and remdesivir can help to reduce mortality in patients with Bundibugyo virus disease, alone or in combination,” World Health Organization (WHO) […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
The Case Against Fauci Was Never About the Origins of COVID-19 11/08/2026 Stefan Anderson For nearly three hours on 29 July, the US Senate Homeland Security and Governmental Affairs Committee heard one sentence repeated over a hundred times. “On the advice of counsel, I respectfully decline to answer based upon my rights under the Fifth Amendment of the Constitution.” Dr Anthony Fauci, the 85-year-old retired director of the National […] Continue reading -> EXCLUSIVE: US Candidates Among Those Shortlisted in Contentious Global Fund Leadership Race 28/06/2026 Felix Sassmannshausen & Elaine Ruth Fletcher As the Global Fund to Fight AIDS, Tuberculosis and Malaria heads into a secretive but highly contentious election of a new Executive Director, the names of several candidates reported to be on the shortlist, all US citizens, have surfaced. They include former Global Fund Executive Director Mark Dybul, former Trump appointee William Steiger and […] Continue reading -> As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon 24/06/2026 Kerry Cullinan A clinical trial of two antivirals that may be effective in treating Ebola Bundibugyo is expected to start in the Democratic Republic of Congo (DRC) next week. “The trial will evaluate whether MVPC 134 and remdesivir can help to reduce mortality in patients with Bundibugyo virus disease, alone or in combination,” World Health Organization (WHO) […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
EXCLUSIVE: US Candidates Among Those Shortlisted in Contentious Global Fund Leadership Race 28/06/2026 Felix Sassmannshausen & Elaine Ruth Fletcher As the Global Fund to Fight AIDS, Tuberculosis and Malaria heads into a secretive but highly contentious election of a new Executive Director, the names of several candidates reported to be on the shortlist, all US citizens, have surfaced. They include former Global Fund Executive Director Mark Dybul, former Trump appointee William Steiger and […] Continue reading -> As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon 24/06/2026 Kerry Cullinan A clinical trial of two antivirals that may be effective in treating Ebola Bundibugyo is expected to start in the Democratic Republic of Congo (DRC) next week. “The trial will evaluate whether MVPC 134 and remdesivir can help to reduce mortality in patients with Bundibugyo virus disease, alone or in combination,” World Health Organization (WHO) […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
As Ebola Cases Breach 1000, Trial of Two Antiviral Treatments Due to Start Soon 24/06/2026 Kerry Cullinan A clinical trial of two antivirals that may be effective in treating Ebola Bundibugyo is expected to start in the Democratic Republic of Congo (DRC) next week. “The trial will evaluate whether MVPC 134 and remdesivir can help to reduce mortality in patients with Bundibugyo virus disease, alone or in combination,” World Health Organization (WHO) […] Continue reading -> Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Industry Demands Repositioning of Medical Innovation as Strategic Investment, Not Cost 21/05/2026 Felix Sassmannshausen Amid surging geopolitical tensions, increased global health threats, and strained public budgets, global health leaders and pharmaceutical executives converged in Geneva with a unified message: medical innovation must be treated as a critical investment not a healthcare drain. Showcasing this shift, Canada unveiled strategic investments and new regulations. GENEVA – Inside the packed ballroom of […] Continue reading -> Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
Pandemic Talks Extended – But Colombia Appeals for New ‘Method’ to Settle Differences 04/05/2026 Kerry Cullinan Colombia has appealed for a new “method” to settle the outstanding annex of the Pandemic Agreement, after World Health Organization (WHO) member states failed to reach agreement last week after almost a year of talks. Talks on a Pathogen Access and Benefit Sharing (PABS) system were due to wrap up last Friday night, but have […] Continue reading -> Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
Smaller Pharma Companies to Bear Brunt of Trump’s 100% Medicine Tariff 07/04/2026 Kerry Cullinan Smaller pharmaceutical companies and those outside countries with trade deals with the US will bear the brunt of President Donald Trump’s 100% tariff on imported patented pharmaceuticals and their active ingredients announced last week. The tariff will be imposed on large companies 120 days from the announcement, and in 180 days for smaller ones. Pharmaceutical […] Continue reading -> Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
Cracking the Cost Code: Why Transparency in TB is a Matter of Life and Death 02/06/2025 Farhat Mantoo & Bern-Thomas Nyang'wa In Nukus, Uzbekistan, 34-year-old surgical nurse Dilaram was devastated when she was diagnosed with drug-resistant tuberculosis (DR-TB). But instead of facing the standard treatment, including nearly 15,000 pills to be taken over two years and painful injections causing severe side effects, she could enrol in TB-PRACTECAL, the MSF-led clinical trial testing an all-oral, six-month regimen […] Continue reading -> Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts
Presidents and Prime Ministers Celebrate the Passing of the Pandemic Agreement 20/05/2025 Kerry Cullinan Presidents, prime ministers and even opera singers, celebrated the unanimous adoption of the world’s first Pandemic Agreement by consensus at the World Health Assembly (WHA) plenary on Tuesday morning. Despite the 11th-hour insistence of Slovakia on a vote on the agreement in Committee A on Monday night, none of the World Health Organization (WHO) member […] Continue reading -> Posts navigation Older postsNewer posts